Katalyze AI: Agentic Infrastructure for Life Sciences
An agentic operating system for pharmaceutical companies that connects fragmented manufacturing and laboratory data with domain-trained AI agents for scientific, engineering and regulated operational workflows.
Visit katalyzeai.com ↗Basic Information
| Field | Detail |
|---|---|
Company Name |
Katalyze AI |
Category |
Enterprise AI |
Subcategory |
Pharmaceutical AI, Agentic Infrastructure & Manufacturing Operations |
Founded |
2025 |
Headquarters |
San Francisco, California, with a Toronto office |
Stage |
Seed |
Total Funding |
$10.5 million |
Latest Funding |
$10.5 million · Seed · July 2026 |
Founders |
Reza Farahani & Shreyas Becker |
Leadership |
Reza Farahani, Co-Founder & CEO · Shreyas Becker, Co-Founder & COO · Hannes Bretschneider, Chief AI Officer |
Key Investors |
Bonfire Ventures, Inovia Capital, Ripple Ventures & Alumni Ventures |
Website |
katalyzeai.com ↗ |
What Katalyze Does
Katalyze connects data from the systems used across pharmaceutical manufacturing and laboratories, then places domain-trained AI agents on top of that operational foundation to investigate problems, assemble records and support regulated workflows.
Key Capabilities
- Unify MES, LIMS, ELN, ERP, historian and other operational data
- Provide a source-grounded ontology and knowledge graph for pharma operations
- Deploy agents for deviation management, process improvement and traceability
- Generate traceable findings and documentation for regulated workflows
- Allow internal scientists and engineers to build proprietary agents through Agent Studio
Why It Matters
Pharmaceutical manufacturing sits inside a highly regulated environment where AI outputs need to be accurate, explainable and traceable. Katalyze is targeting the operational layer between fragmented enterprise data and the decisions made by scientists and engineers.
Katalyze at Scale
5 / 20
Top Pharma Companies
Katalyze says its platform is deployed at sites belonging to five of the 20 largest global pharmaceutical companies.
10M
Medication Doses
The company says its platform has enabled pharmaceutical teams to deliver 10 million medication doses with greater operational speed and visibility.
100+
Industry Experts
Katalyze works with more than 100 tenured scientists and engineers from companies including Pfizer, Sanofi and Lilly to develop domain-specific agent skills.
Enterprise Momentum
Regulated by Design
Katalyze is designed around GxP requirements, data privacy, data sovereignty and auditability so AI agents can operate within pharmaceutical governance requirements.
Sanofi Deployment
Sanofi is among the pharmaceutical organizations using Katalyze. The company has highlighted deployments involving operational data, quality workflows and manufacturing analysis.
Fast Deployment
Katalyze says most teams can be live in weeks, using more than 40 connectors to work across the systems already used by pharmaceutical organizations.
Agentic Infrastructure for Pharma
Context Layer
The Primary Production Record connects batches, lots, deviations, samples, instruments and specifications into a source-anchored operational model that agents can reason over and people can verify.
Domain Agents
Katalyze provides agents for areas such as deviation investigations, process improvement, tech transfer and traceability, with skills designed around pharmaceutical operations.
Agent Studio
Internal scientists and data engineers can create proprietary agents on the same governed infrastructure, allowing companies to encode specialized operational knowledge into reusable workflows.
Funding Journey
2025
Company Founded
Katalyze
Founded by Reza Farahani and Shreyas Becker
July 2026
Seed
$10.5M
Led by Bonfire Ventures
July 2026
Enterprise Deployment
5 / 20
Top global pharma companies with deployments
2026
Platform Expansion
40+
Connectors across pharma cloud, lab and quality systems